NovoCure (NVCR) logo

NovoCure (NVCR) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -3

9 insiders sold $948K. No buys.

SellMichal Nath Puri$9KChief Human Resources Officerat $13.24 on Nov 2, filed yesterday
SellFrank X. Leonard$615KChief Executive Officerat $17.93 on Jun 4, filed Jun 5
SellGabriel Leung$46KDirectorat $15.77 on Jun 2, filed Jun 3

From SEC Form 4s, the newest filed Nov 4, 2026 · Insiders have 2 business days to file a trade

6 more filings on NVCR in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 9 tradesSee it live, free until Saturday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on NVCR with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at NovoCure

  • Allyson J. OceanDirector · 1 sale
  • David HungDirector · 1 sale
  • Frank X. LeonardChief Executive Officer · 1 sale
  • Gabriel LeungDirector · 1 sale
  • Jeryl L. HillemanDirector · 1 sale
  • Kristin StaffordDirector · 1 sale
  • Michal Nath PuriChief Human Resources Officer · 1 sale
  • Timothy J. ScannellDirector · 1 sale
Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about NVCR's insider trades

As of Nov 5, 2026: NovoCure (NVCR) has 9 insider filings on record in the last 6 months, the newest filed Nov 4, 2026. Its Quality Score is -3 (Poor). Scores as of 6:35 PM ET, 15 minutes behind.

Are NVCR insiders buying or selling?

9 insiders sold $948K across 9 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Michal Nath Puri, Chief Human Resources Officer, sold $9K on Nov 2, 2026.

Who are NVCR's biggest insider sellers?

By the dollars of their sales in the last 6 months: Frank X. Leonard (Chief Executive Officer), 1 sale; Allyson J. Ocean (Director), 1 sale; David Hung (Director), 1 sale. 9 insiders sold in all.

When did an NVCR insider last buy?

No NVCR insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Michal Nath Puri on Nov 2, 2026.

NovoCure's page has its Quality Score, its chart, and its earnings. More in Healthcare and Medical Devices.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.